The single-use bioreactors market is on a robust growth trajectory, with projections indicating it will surpass $9.1 billion by 2028. This impressive growth underscores the increasing adoption of single-use technologies in bioprocessing and the pivotal role they play in advancing the biotechnology and pharmaceutical industries.
Download an Illustrative overview:
Single-use bioreactors, also known as disposable bioreactors, have revolutionized the way bioprocesses are conducted by providing a cost-effective, flexible, and efficient alternative to traditional stainless-steel systems. Their popularity stems from their ability to minimize cross-contamination risks, reduce operational costs, and streamline manufacturing processes.
Key drivers behind this market surge include:
Increased Biopharmaceutical Production: The rise in demand for biopharmaceuticals, including monoclonal antibodies and gene therapies, has fueled the need for efficient and scalable production systems. Single-use bioreactors offer the flexibility to rapidly adapt to different production requirements.
Advancements in Technology: Continuous innovations in single-use bioreactor technology, such as improved control systems and enhanced materials, have expanded their applications across various stages of bioprocessing.
Cost Efficiency: The reduction in capital and operational expenditures associated with single-use systems compared to traditional stainless-steel alternatives is driving widespread adoption.
Regulatory Support: Favorable regulatory guidelines and growing recognition of single-use bioreactors' benefits are further accelerating their integration into bioprocessing workflows.
"Single-use bioreactors are transforming the landscape of bioprocessing," saidMarketsandMarkets. "Their scalability, efficiency, and cost-effectiveness are pivotal in meeting the increasing demands of the biopharmaceutical industry. As we move forward, we anticipate continued innovation and growth in this sector."
The single-use bioreactors market encompasses various segments, including upstream and downstream processes, with applications spanning cell culture, fermentation, and purification. As the bioprocessing industry evolves, single-use bioreactors are set to play an even more significant role in enhancing production capabilities and accelerating time-to-market for new therapies.
Content Source:
https://www.marketsandmarkets.com/PressReleases/single-use-bioreactor.asp
https://www.marketsandmarkets.com/ResearchInsight/single-use-bioreactor-market.asp
About MarketsandMarkets™:
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
